Midlothian Labs Distributes Generic Oxycodone Capsules
The U.S. Food and Drug Administration approved the abbreviated new drug application July 26. This new AB-rated product is the first approved generic for the Reference Listed Drug (RLD) Oxycodone HCl 5 mg capsules manufactured by Lehigh Valley Technologies Inc.
“Now more than ever, participants of our health-care system – whether they are patients, doctors, pharmacists or insurers – are extremely concerned about containing costs while continuing to provide excellent care,” said Bryce M. Harvey, president of Midlothian Laboratories. “In taking this step, Midlothian Labs is providing doctors and pharmacists an affordable and high-quality alternative for their patients who need this analgesic.”
Midlothian Laboratories is a pharmaceutical company that focuses on providing niche generic products to the U.S. market. Chartered in 2002, Midlothian is headquartered in Montgomery, Ala. Midlothian currently is marketing and distributing its products to national pharmaceutical wholesalers, chain drug stores and retail merchandisers.
Source: Midlothian Laboratories